Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Pain and Blood Loss in Cesarean Delivery
NCT02509312Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ketorolac Group with Placebo Group (2 arms). Primary endpoint: Estimated Blood Loss. Started May 2016; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02509312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509312.